3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

NCT04250636 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: 3BNC117-LS
DRUG: 10-1074-LS

Sponsor

Rockefeller University

Collaborators

[object Object]
[object Object]
[object Object]